[PDF][PDF] Prevalence of HER-2-positive invasive breast cancer: a systematic review from Iran

E Keyhani, A Muhammadnejad… - Asian Pacific Journal …, 2012 - pdfs.semanticscholar.org
Abstract Background: The HER-2/neu gene is altered in 15-20% of breast cancer patients.
Immunohistochemistry (IHC) is considered to be the most cost-effective method for HER-2 …

A probabilistic data analytics methodology based on Bayesian Belief network for predicting and understanding breast cancer survival

AZ Dag, Z Akcam, E Kibis, S Simsek, D Delen - Knowledge-Based Systems, 2022 - Elsevier
Understanding breast cancer survival has proven to be a challenging problem for
practitioners and researchers. Identifying the factors affecting cancer progression, their …

[HTML][HTML] Correlation between age and hormone receptor status in women with breast cancer

A Shah, G Haider, N Abro, S Bhutto, TI Baqai, S Akhtar… - Cureus, 2022 - ncbi.nlm.nih.gov
Methods A cross-sectional study was conducted at the Department of Medical Oncology,
Jinnah Postgraduate Medical Center (JPMC), Karachi, Pakistan, from January 2021 to …

Comparison of clinicopathological features and treatments between young (≤ 40 years) and older (> 40 years) female breast cancer patients in West China: a …

K Wang, Y Ren, H Li, K Zheng, J Jiang, T Zou, B Ma… - PloS one, 2016 - journals.plos.org
The incidence of young cases of breast cancer is higher in China compared to the western
world. We aimed to explore differences in risk factors, clinicopathological features and …

Very young breast cancer in a referral center in Tehran, Iran: Review of 55 Cases Aged 25 or Less throughout 33 Years

S Alipour, R Omranipour, I Jahanzad… - Asian Pacific Journal of …, 2013 - journal.waocp.org
Background: Breast cancer is mostly the disease of postmenopausal women but very young
affected womenare seen more than occasionally in developing countries. We reviewed our …

Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients

A Herrera, C Panis, VJ Victorino, FC Campos… - Cancer Immunology …, 2012 - Springer
Breast cancer consists in a chronic inflammatory disease with multiple biological and clinical
behaviors. Based on high throughput technologies data, this disease is currently classified …

[HTML][HTML] Breast cancer in Jamaica: stage, grade and molecular subtype distributions across age blocks, the implications for screening and treatment

J Copeland, A Oyedeji, N Powell… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Background Breast cancer is the most commonly diagnosed and leading cause of cancer-
related morbidity and mortality in females worldwide. Significant disparities exist in breast …

Association of hormone receptors and human epidermal growth factor receptor-2/neu expressions with clinicopathologic factors of breast carcinoma: a cross-sectional …

E Esmat, AM Haidary, R Saadaat, SN Rizvi, S Aleena… - BMC cancer, 2024 - Springer
Background Breast cancer (BC) is one of the major causes of death worldwide. It is the most
common cause of death before the age of 70 years. The incidence and mortality of BC are …

Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajan in breast cancer cells

Y Fu, O Kadioglu, B Wiench, Z Wei, C Gao, M Luo… - Phytomedicine, 2015 - Elsevier
Background: The low abundant cajanin stilbene acid (CSA) from Pigeon Pea (Cajanus
cajan) has been shown to kill estrogen receptor α positive cancer cells in vitro and in vivo …

Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es …

AR Mwakigonja, NE Lushina, A Mwanga - Infectious agents and cancer, 2017 - Springer
Background Breast cancer is a leading cause of morbidity and deaths among women
worldwide. In Tanzania there is no published data on human epidermal growth receptor-2 …